Loading…

PB2221: AN OPEN‐LABEL, PHASE 1/1B STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS, PHARMACODYNAMICS AND CLINICAL ACTIVITY OF IMETELSTAT IN COMBINATION WITH RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS: IMPROVEMF

Saved in:

Bibliographic Details
Published in:	HemaSphere 2023-08, Vol.7 (S3), p.e906057e-n/a
Main Authors:	Kuykendall, Andrew, Bradley, Terrence, Komrokji, Rami S., Berry, Tymara, Dougherty, Souria, Sherman, Laurie, Peng, Lixian, Huang, Fei, Wan, Ying, Rodolf, Vivian, Ho, Judy, Navada, Shyamala, Mascarenhas, John
Format:	Article
Language:	English
Subjects:	Publication Only
Citations:	Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!